We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Coupang
CPNG
$27.7B
| $257K | 0.13% |
+10,891
| New | +$310K |
|
377
Sunstone Hotel Investors
SHO
$2.19B
| $257K | 0.13% |
+28,730
| New | +$264K |
|
378
T-Mobile US
TMUS
$196B
| $257K | 0.13% |
+1,265
| New | +$268K |
|
379
Alphatec Holdings
ATEC
$1.43B
| $256K | 0.13% |
+12,179
| New | +$225K |
|
380
Coca-Cola Europacific Partners
CCEP
$49.3B
| $256K | 0.13% |
+2,824
| New | +$255K |
|
381
BRC Group Holdings
RILY
$270M
| $256K | 0.13% |
+54,768
| New | +$271K |
|
382
Compass Minerals
CMP
$1.25B
| $255K | 0.13% |
+13,003
| New | +$241K |
|
383
Coca-Cola
KO
$380B
| $253K | 0.13% |
3,612
+87
| +2% | +$6.07K |
|
384
Consolidated Water Co
CWCO
$484M
| $252K | 0.13% |
7,134
-192
| -3% | -$6.7K |
|
385
Portland General Electric
POR
$5.92B
| $251K | 0.13% |
+5,227
| New | +$247K |
|
386
Centrus Energy
LEU
$3.34B
| $251K | 0.13% |
+1,033
| New | +$312K |
|
387
Travelers Companies
TRV
$82.9B
| $251K | 0.13% |
+864
| New | +$243K |
|
388
Uber
UBER
$144B
| $250K | 0.13% |
+3,060
| New | +$276K |
|
389
Netflix
NFLX
$301B
| $250K | 0.13% |
2,663
-697
| -21% | -$75.1K |
|
390
Bridgewater Bancshares
BWB
$585M
| $249K | 0.13% |
+14,216
| New | +$247K |
|
391
Amphenol
APH
$177B
| $249K | 0.13% |
1,839
-684
| -27% | -$91.5K |
|
392
Viper Energy
VNOM
$8.21B
| $248K | 0.13% |
6,431
+727
| +13% | +$27.5K |
|
393
Ecolab
ECL
$79.6B
| $248K | 0.13% |
+946
| New | +$252K |
|
394
Healthpeak Properties
DOC
$15.7B
| $248K | 0.13% |
+15,429
| New | +$272K |
|
395
Mativ Holdings
MATV
$482M
| $248K | 0.13% |
20,409
+9,198
| +82% | +$108K |
|
|
BFS
396
Saul Centers
BFS
$870M
| $248K | 0.13% |
+7,862
| New | +$242K |
|
397
Motorcar Parts of America
MPAA
$267M
| $247K | 0.13% |
20,032
-3,994
| -17% | -$57.5K |
|
398
Arm
ARM
$261B
| $247K | 0.13% |
+2,261
| New | +$329K |
|
399
AvePoint
AVPT
$2.74B
| $247K | 0.13% |
17,788
-2,742
| -13% | -$37.9K |
|
|
MBAV
400
DELISTED
M3-Brigade Acquisition V Corp
MBAV
| $247K | 0.13% |
+23,238
| New | +$247K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.